Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study

CVD-REAL Investigators and Study Group

Research output: Contribution to journalArticlepeer-review

250 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study'. Together they form a unique fingerprint.

Medicine & Life Sciences